682
Background:
In the United States, >170,000 individuals are living with metastatic breast cancer (mBC). New treatments continue to emerge and vary by mode of delivery, length, side effects, and costs. While providers share information about potential risks and benefits of different treatments, accounting for...
Laura C. Pinheiro, Z. Hamilton, Darima Dorzhieva et al.· JCO Oncology Practice· 0 citations
Engaging underrepresented populations in clinical trials remains a persistent challenge. To promote equitable participation in a hybrid decentralized study (i.e., recruitment and enrollment at sites or virtually), we created a national community advisory board (CAB), defined as a group of community members who help g...
S. Krinshpun, Catherine A. Dayger, E. Hoffman et al.· Cancer Epidemiology, Biomark...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.